BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 25045845)

  • 1. The telomere/telomerase binding factor PinX1 regulates paclitaxel sensitivity depending on spindle assembly checkpoint in human cervical squamous cell carcinomas.
    Tian XP; Qian D; He LR; Huang H; Mai SJ; Li CP; Huang XX; Cai MY; Liao YJ; Kung HF; Zeng YX; Xie D
    Cancer Lett; 2014 Oct; 353(1):104-14. PubMed ID: 25045845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The telomere/telomerase binding factor PinX1 is a new target to improve the radiotherapy effect of oesophageal squamous cell carcinomas.
    Qian D; Zhang B; He LR; Cai MY; Mai SJ; Liao YJ; Liu YH; Lin MC; Bian XW; Zeng YX; Huang JJ; Kung HF; Xie D
    J Pathol; 2013 Apr; 229(5):765-74. PubMed ID: 23341363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Pinx1 Gene Downregulates Telomerase and Inhibits Proliferation of CD133+ Cancer Stem Cells Isolated from a Nasopharyngeal Carcinoma Cell Line by Regulating Trfs and Mad1/C-Myc/p53 Pathways.
    Shen C; Chen F; Wang H; Li G; Yu C; Wang X; Wen Z
    Cell Physiol Biochem; 2018; 49(1):282-294. PubMed ID: 30138944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High expression of survivin predicts poor prognosis in cervical squamous cell carcinoma treated with paclitaxel and carboplatin.
    Zhang Y; Yan H; Li R; Guo Y; Zheng R
    Medicine (Baltimore); 2019 May; 98(20):e15607. PubMed ID: 31096466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of paclitaxel, ifosfamide, and cisplatin as a neoadjuvant chemotherapy in locally advanced cervical carcinoma.
    Scandurra G; Scibilia G; Banna GL; D'Agate G; Lipari H; Gieri S; Scollo P
    J Gynecol Oncol; 2015 Apr; 26(2):118-24. PubMed ID: 25686397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PinX1 is involved in telomerase recruitment and regulates telomerase function by mediating its localization.
    Cheung DH; Kung HF; Huang JJ; Shaw PC
    FEBS Lett; 2012 Sep; 586(19):3166-71. PubMed ID: 22749911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of spindly delays mitotic exit and exacerbates cell death response of cancer cells treated with low doses of paclitaxel.
    Silva PM; Ribeiro N; Lima RT; Andrade C; Diogo V; Teixeira J; Florindo C; Tavares Á; Vasconcelos MH; Bousbaa H
    Cancer Lett; 2017 May; 394():33-42. PubMed ID: 28249757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corrigendum to ‟The telomere/telomerase binding factor PinX1 regulates paclitaxel sensitivity depending on spindle assembly checkpoint in human cervical squamous cell carcinomas" [Canc. Lett. 353 (2014) 104-114].
    Tian XP; Qian D; He LR; Huang H; Mai SJ; Li CP; Huang XX; Cai MY; Liao YJ; Kung HF; Zeng YX; Xie D
    Cancer Lett; 2021 Sep; 516():61-63. PubMed ID: 34091434
    [No Abstract]   [Full Text] [Related]  

  • 9. Corrigendum to "The telomere/telomerase binding factor PinX1 regulates paclitaxel sensitivity depending on spindle assembly checkpoint in human cervical squamous cell carcinomas" [Canc. Lett. 353 (2014) 104-114].
    Tian XP; Qian D; He LR; Huang H; Mai SJ; Li CP; Huang XX; Cai MY; Liao YJ; Kung HF; Zeng YX; Xie D
    Cancer Lett; 2021 Oct; 519():345. PubMed ID: 34353674
    [No Abstract]   [Full Text] [Related]  

  • 10. Expression and mechanism of PinX1 and telomerase activity in the carcinogenesis of esophageal epithelial cells.
    Zuo J; Wang DH; Zhang YJ; Liu L; Liu FL; Liu W
    Oncol Rep; 2013 Oct; 30(4):1823-31. PubMed ID: 23912465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PinX1, a novel target gene of p53, is suppressed by HPV16 E6 in cervical cancer cells.
    Wu G; Liu D; Jiang K; Zhang L; Zeng Y; Zhou P; Zhong D; Gao M; He F; Zheng Y
    Biochim Biophys Acta; 2014 Feb; 1839(2):88-96. PubMed ID: 24412852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silencing PinX1 compromises telomere length maintenance as well as tumorigenicity in telomerase-positive human cancer cells.
    Zhang B; Bai YX; Ma HH; Feng F; Jin R; Wang ZL; Lin J; Sun SP; Yang P; Wang XX; Huang PT; Huang CF; Peng Y; Chen YC; Kung HF; Huang JJ
    Cancer Res; 2009 Jan; 69(1):75-83. PubMed ID: 19117989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous targeting of telomeres and telomerase as a cancer therapeutic approach.
    Mo Y; Gan Y; Song S; Johnston J; Xiao X; Wientjes MG; Au JL
    Cancer Res; 2003 Feb; 63(3):579-85. PubMed ID: 12566299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy with cisplatin and paclitaxel in locally advanced cervical cancer: has this regimen still a role as neoadjuvant setting?
    Moioli M; Papadia A; Mammoliti S; Pacella E; Menoni S; Menada MV; Ragni N
    Minerva Ginecol; 2012 Apr; 64(2):95-107. PubMed ID: 22481620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic effects of antibiotic drug tigecycline against cervical squamous cell carcinoma by inhibiting Wnt/β-catenin signaling.
    Li H; Jiao S; Li X; Banu H; Hamal S; Wang X
    Biochem Biophys Res Commun; 2015 Nov; 467(1):14-20. PubMed ID: 26427870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 6,7-Dimethoxy-3-(3-methoxyphenyl)isoquinolin-1-amine induces mitotic arrest and apoptotic cell death through the activation of spindle assembly checkpoint in human cervical cancer cells.
    Chung KS; Choi HE; Shin JS; Cho YW; Choi JH; Cho WJ; Lee KT
    Carcinogenesis; 2013 Aug; 34(8):1852-60. PubMed ID: 23615402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-181a enhances the chemoresistance of human cervical squamous cell carcinoma to cisplatin by targeting PRKCD.
    Chen Y; Ke G; Han D; Liang S; Yang G; Wu X
    Exp Cell Res; 2014 Jan; 320(1):12-20. PubMed ID: 24183997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant paclitaxel and cisplatin in uterine cervical cancer: long-term results.
    Park DC; Suh MJ; Yeo SG
    Int J Gynecol Cancer; 2009 Jul; 19(5):943-7. PubMed ID: 19574789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amplification and up-regulation of MIR30D was associated with disease progression of cervical squamous cell carcinomas.
    Zhou Y; Hao Y; Li Y; Li R; Wu R; Wang S; Fang Z
    BMC Cancer; 2017 Mar; 17(1):230. PubMed ID: 28356144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The platinum compounds and paclitaxel in the management of carcinomas of the endometrium and uterine cervix.
    Thigpen T; Vance RB; Khansur T
    Semin Oncol; 1995 Oct; 22(5 Suppl 12):67-75. PubMed ID: 7481864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.